NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Astorg, a pan-European private equity firm, signed a definitive agreement to acquire the microbiology business from Thermo Fisher Scientific.Read More